Publication date: January 19, 2026
A regulated market is a system for trading in financial instruments admitted to trading. It operates according to the rules established by the entity operating the market and is supervised by the Polish Financial Supervision Authority. It is the most formal and strictly regulated type of market. It must be based on transparency, equal access, and disclosure requirements. Shares, bonds, and other securities are permitted on the market. The goal of this market is to ensure safe and fair trading in financial instruments. Market participants include banks, companies, investment firms, and investors.
An auction platform is a specialized type of organized market. It is used for the sale of specific instruments – most commonly CO2 emission allowances—through auctions. The Act of 29 July 2005 on Trading in Financial Instruments is one of the most important legal acts of the Polish capital market. It regulates the operation of the securities and other financial instruments trading market, as well as the activities of investment firms, stock exchanges, trading platforms, and financial supervision. Pursuant to the Act on Trading in Financial Instruments, the Regulation of the Minister of Finance was issued on July 23, 2025, amending the Regulation of April 12, 2019, on detailed conditions that must be met by the regulated market and the auction platform.
More
Publication date: January 19, 2026
What is the place of delivery/place of performance?
Article 5, paragraph 1 of the VAT Act
The following are subject to value added tax (VAT):
1) paid supply of goods and paid provision of services within the territory of the country;
2) export of goods;
3) import of goods within the territory of the country;
4) intra-Community acquisition of goods for remuneration within the territory of the country; 5) intra-Community supply of goods.
More
Publication date: January 19, 2026
Notarial deed as an official document within the meaning of the provisions of the Code of Civil Procedure
Pursuant to Article 2 section 2 of the Act of 14 February 1991 – The Notarial Law, notarial acts (including notarial deeds) performed by a notary in accordance with the law have the nature of an official document. From this clear statement, it can be inferred that the provisions of the Code of Civil Procedure regarding official documents apply to notarial deeds. This is also confirmed by the case law of the Polish Supreme Court (including in its judgment of 9 August 2019, II CSK 341/18). Under procedural provisions, the distinction between official documents is significant, primarily in the area of evidence.
More
Publication date: January 16, 2026
Pharmaceutical production is one of the most regulated activities in Poland, Europe, and globally. The reason seems obvious: creating drugs can cause numerous complications, health problems, and in extreme cases, even death, depending on the individual patient’s health contraindications. Due to the above-mentioned reasons, the process of creating a new drug is often very expensive and lengthy, and involves a large number of professionals and scientists specializing in this field. In an era of dynamic digitalization, the need to develop specific operational rules for drug production and principles for using AI (Artificial Intelligence) and ML (Machine Learning) models is increasingly emphasized. Manufacturers are often considering implementing AI systems to support pharmaceutical production processes.
More
Publication date: January 16, 2026
On January 15, 2026, our colleague, Zofia Kubic, had the opportunity to participate in the LifeScience Kraków Cluster meeting, representing the KG Legal Kiełtyka Gładkowski law firm, a member of the cluster. The meeting was held as a Cluster Breakfast and was concise and strategic in nature, focusing primarily on the organization’s development plans for the coming year and beyond. Additionally, 2026 was considered a special year in the Cluster’s history, marking its 20th anniversary.
During the meeting, it was emphasized at the outset that the Cluster would continue its activities in its existing key areas. These included: bioeconomy, healthcare technology, innovative therapies and medical devices, diagnostics, and preventive healthcare. Emphasizing these areas was intended to confirm the continuity of the Cluster’s strategy and further direct its activities, including through the development of roadmaps and the development of cooperation between partners operating in these sectors.
More
